Cargando…

Assessment of Biomarker Testing for Lung Cancer Screening Eligibility

This exploratory study analyzes the cost-effectiveness of incorporating biomarkers into eligibility assessment for lung screening.

Detalles Bibliográficos
Autores principales:	Larose, Tricia L., Meheus, Filip, Brennan, Paul, Johansson, Mattias, Robbins, Hilary A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059020/ https://www.ncbi.nlm.nih.gov/pubmed/32134462 http://dx.doi.org/10.1001/jamanetworkopen.2020.0409

Ejemplares similares

A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil
por: Miranda-Filho, Adalberto, et al.
Publicado: (2021)

Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom
por: Robbins, Hilary A., et al.
Publicado: (2021)

Eligibility for Lung Cancer Screening Among Women Receiving Screening for Breast Cancer
por: Titan, Ashley L., et al.
Publicado: (2022)

RACIAL AND ETHNIC DIFFERENCES IN LUNG CANCER SCREENING ELIGIBILITY AND HEALTH CARE UTILIZATION AMONG OLDER SMOKERS
por: Avila, Jaqueline, et al.
Publicado: (2022)

Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
por: Waterboer, Tim, et al.
Publicado: (2020)

Methods for Using Race and Ethnicity in Prediction Models for Lung Cancer Screening Eligibility
por: Landy, Rebecca, et al.
Publicado: (2023)

Analysis of Lung Cancer Screening by Race After USPSTF Expansion of Screening Eligibility in 2021
por: Shusted, Christine S., et al.
Publicado: (2022)

Lung Cancer Screening Eligibility and Screening Patterns Among Black and White Adults in the United States
por: Lozier, Jessica W., et al.
Publicado: (2021)

Prevalence of Lung Cancer Screening Among Eligible Adults in 4 US States in 2021
por: Maki, Kristin G., et al.
Publicado: (2023)

Estimating Pack-Year Eligibility for Lung Cancer Screening Using 2 Yes or No Questions
por: Rendle, Katharine A., et al.
Publicado: (2023)

Telephone risk-based eligibility assessment for low-dose CT lung cancer screening
por: Dickson, Jennifer L, et al.
Publicado: (2022)

Using Electronic Medical Records to Identify Potentially Eligible Study Subjects for Lung Cancer Screening with Biomarkers
por: Brown, Lamorna, et al.
Publicado: (2021)

The criteria of eligibility to the extracorporeal treatment
por: Zangrillo, A
Publicado: (2012)

Data on Medicare eligibility and cancer screening utilization
por: Meyer, Christian P., et al.
Publicado: (2016)

Accuracy of Dysphagia Standard Assessment (DSA®) bedside screening test: a flowchart for patient eligibility
por: Mariani, Laura, et al.
Publicado: (2022)

Barriers, Facilitators, and Suggested Interventions for Lung Cancer Screening Among a Rural Screening-Eligible Population
por: Schiffelbein, Jenna E., et al.
Publicado: (2020)

Access to Care Limits Lung Cancer Screening Eligibility in an Urban Safety Net Hospital
por: Dollar, Krista R., et al.
Publicado: (2022)

Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study
por: Callender, Thomas, et al.
Publicado: (2023)

The impact of income and education on lung cancer screening utilization, eligibility, and outcomes: a narrative review of socioeconomic disparities in lung cancer screening
por: Castro, Samuel, et al.
Publicado: (2021)

The impact of perceived risk, screening eligibility and worry on preference for lung cancer screening: a cross-sectional survey
por: See, Katharine, et al.
Publicado: (2020)

Impact of U.S. Preventive Services Task Force lung cancer screening update on drivers of disparities in screening eligibility
por: Maki, Kristin G., et al.
Publicado: (2022)

Effect of Mailed Fecal Immunochemical Test Outreach for Patients Newly Eligible for Colorectal Cancer Screening
por: Burns, Shohei, et al.
Publicado: (2023)

ELIGIBILITY FOR LOW-DOSE COMPUTED TOMOGRAPHY LUNG CANCER SCREENING IN OLDER ASIAN AMERICAN SMOKERS
por: Li, Chien-Ching, et al.
Publicado: (2019)

Burden of male hardcore smokers and its characteristics among those eligible for lung cancer screening
por: Park, Dong Won, et al.
Publicado: (2020)

Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer
por: Zarinshenas, Reza, et al.
Publicado: (2023)

Attributes Characterizing Colorectal Cancer Screening Tests That Influence Preferences of Individuals Eligible for Screening in Germany: A Qualitative Study
por: Brinkmann, Melanie, et al.
Publicado: (2022)

Lung Cancer Care Before and After Medicare Eligibility
por: Huesch, Marco D., et al.
Publicado: (2016)

Differential eligibility of African American and European American lung cancer cases using LDCT screening guidelines
por: Ryan, Bríd M
Publicado: (2016)

Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement
por: Rivera, M. Patricia, et al.
Publicado: (2020)

Lung Cancer Screening Eligibility and Referral Practices in Texas Organizations Serving People with Substance Use Disorders
por: Britton, Maggie, et al.
Publicado: (2023)

USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study
por: Tammemägi, Martin C, et al.
Publicado: (2022)

Potential Epigenetic Biomarkers for Prostate Cancer Screening
por: Bae, Jong-Myon
Publicado: (2018)

Analysis of Eligibility for Lung Cancer Screening by Race After 2021 Changes to US Preventive Services Task Force Screening Guidelines
por: Pinheiro, Laura C., et al.
Publicado: (2022)

To the editor: S‐ICD eligibility in adult congenital heart disease
por: Wang, Linda, et al.
Publicado: (2021)

Characteristics of Hospitals Eligible for Rural Emergency Hospital Designation
por: Chatterjee, Paula, et al.
Publicado: (2022)

State-Level Variability in Hospital Presumptive Eligibility Programs
por: Gibson, Alexander B., et al.
Publicado: (2023)

Inconsistencies and questionable reliability of the publication “Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophages-activating, GcMAF” by Yamamoto et al
por: Ugarte, Ana, et al.
Publicado: (2014)

Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force
por: Liu, Yu, et al.
Publicado: (2022)

Early Adherence to Lung Cancer Screening
por: Zulueta, Javier J., et al.
Publicado: (2021)

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs
por: Haslam, Alyson, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mru5ghq1f5t5evkb0asm3gljhr